Tenders

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Nswc Dahlgren Baa N00178-25-0002

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Guselkumab (Exclusively in the Potency 100Mg), (Obo), Atc L04ac16 for the Period December 1St, 2024 - November 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Botulinum Toxin Type a (Obo), Atc M03ax21 for the Period December 1St, 2024 - November 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Glatiramer Acetate (Exclusively Pre-Filled Syringes), (Obo), Atc L03ax13 for the Period December 1St, 2024 - November 30Th...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Cladribine (Obo), Atc L04aa40 for the Period December 1St, 2024 - November 30Th, 2026

Acquisition of Rehabilitative Institutional Care

Provision of Forest Management Services in the Łopuchowko Forest District in 2025

Expansion and Renovation of Comenius Special School (53)